PMCB
PharmaCyte Biotech Inc
Price:  
1.1 
USD
Volume:  
26,479
United States | Biotechnology

PMCB Relative Valuation

3.8 %
Upside

As of 2025-07-08, the Relative Valuation of PharmaCyte Biotech Inc (PMCB) is 1.14 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.10 USD, the upside of PharmaCyte Biotech Inc based on Relative Valuation is 3.8%.

The range of the Relative Valuation is 1.1 - 1.18 USD.

Range Selected
Trailing P/E multiples0.4x - 0.4x0.4x
Forward P/E multiples 22.0x - 22.0x22x
Fair Price1.1 - 1.181.14
Upside0.2% - 7.4%3.8%
1.10 USD
Stock Price
1.14 USD
Fair Price
Relative Valuation

PMCB Relative Valuation - Benchmarking P/E against peers

(USD in millions except Fair Price)
Market Cap (USD mil)Trailing P/EForward P/E
PharmaCyte Biotech Inc80.4x22x
Industry median0.4x22x
(*) Profit after tax200
Equity value88
(/) Outstanding shares77
Fair price11

PMCB Relative Valuation - Historical P/E Data

July 07, 20250.37
July 03, 20250.38
July 02, 20250.39
July 01, 20250.39
June 30, 20250.37
June 27, 20250.35
June 26, 20250.36
June 25, 20250.35
June 24, 20250.36
June 23, 20250.36
June 20, 20250.36
June 18, 20250.36
June 17, 20250.36
June 16, 20250.34
June 13, 20250.34
June 12, 20250.35
June 11, 20250.37
June 10, 20250.37
June 09, 20250.35
June 06, 20250.35
June 05, 20250.38
June 04, 20250.37
June 03, 20250.37
June 02, 20250.36
May 30, 20250.35
May 29, 20250.35
May 28, 20250.36
May 27, 20250.34
May 23, 20250.36
May 22, 20250.35
May 21, 20250.35
May 20, 20250.35
May 19, 20250.35
May 16, 20250.36
May 15, 20250.35
May 14, 20250.35
May 13, 20250.36
May 12, 20250.36
May 09, 20250.38
May 08, 20250.39
May 07, 20250.37
May 06, 20250.38
May 05, 20250.41
May 02, 20250.41
May 01, 20250.4
April 30, 20250.42
April 29, 20250.42
April 28, 20250.41
April 25, 20250.41
April 24, 20250.41